Lantern Pharma Inc. (LTRN)
$2.11-9.83%Close
SELLCRISIS · day 9
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $27M
- Avg volume
- 214.6K
- Beta
- 2.33
- P/E (TTM)
- -1.30
- Short % float
- 8.82%
- Days to cover
- 10.1
- SI change
- -10.5%
- 1W
- -18.85%
- 1M
- -23.27%
- 3M
- -39.71%
- YTD
- -32.15%
- vs SPY 1W
- -17.66%
- vs SPY 1M
- -26.59%
- vs SPY 3M
- -42.11%
- vs SPY YTD
- -43.91%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- PCSASELLProcessa Pharmaceuticals, Inc.CRISISQ -10$2.17+4.33%
- RDHLSELLRedHill Biopharma Ltd.RECOVERYQ -15$0.61-3.17%
- XRAYSELLDENTSPLY SIRONA Inc.CRISISQ 1$10.89-0.27%
- LSBBUYLakeShore Biopharma Co., LtdCRISISQ -25$0.63-19.23%
- NTRABUYNatera, Inc.BULLQ 29$327.72-1.30%
- TALKBUYTalkspace, Inc.BULLQ 1$5.25+0.00%
- MIRMSELLMirum Pharmaceuticals, Inc.CRISISQ 38$96.72+0.43%
- PRQRBUYProQR Therapeutics N.V.RECOVERYQ 6$2.43+3.85%
- PDSBSELLPDS Biotechnology CorporationCRISISQ -21$0.22+0.00%
- PRGOBUYPerrigo Company plcRECOVERYQ 1$14.27+0.14%
- TPSTBUYTempest Therapeutics, Inc.RECOVERYQ -8$1.10+5.77%
- STXSBUYStereotaxis, Inc.RECOVERYQ 5$1.42+0.00%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 10
- VALUE
- 5
- GROWTH
- 37
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-273.8%
REV YoY-
ROE-456.4%
EPS YoY-
ROA-216.8%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-1.30
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B-8.15
P/FCF-
EV/EBITDA-1.09
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO1.96
ND/EBITDA-
BETA2.33
